Abstract:Gallbladder (GB) carcinoma, although relatively rare, is the most common biliary tree cholangiocarcinoma with aggressiveness and poor prognosis. It is closely associated with cholelithiasis and long-standing large (> 3 cm) gallstones in up to 90% of cases. The other main predisposing factors for GB carcinoma include molecular factors such as mutated genes, GB wall calcification (porcelain) or mainly mucosal microcalcifications, and GB polyps ≥ 1 cm in size. Diagnosis is made by ultrasound, computed tomography (CT), and, more precisely, magnetic resonance imaging (MRI). Preoperative staging is of great importance in decision-making regarding therapeutic management. Preoperative staging is based on MRI findings, the leading technique for liver metastasis imaging, enhanced three-phase CT angiography, or magnetic resonance angiography for major vessel assessment. It is also necessary to use positron emission tomography (PET)-CT or 18F-FDG PET-MRI to more accurately detect metastases and any other occult deposits with active metabolic uptake. Staging laparoscopy may detect dissemination not otherwise found in 20%-28.6% of cases. Multimodality treatment is needed, including surgical resection, targeted therapy by biological agents according to molecular testing gene mapping, chemotherapy, radiation therapy, and immunotherapy. It is of great importance to understand the updated guidelines and current treatment options. The extent of surgical intervention depends on the disease stage, ranging from simple cholecystectomy (T1a) to extended resections and including extended cholecystectomy (T1b), with wide lymph node resection in every case or IV-V segmentectomy (T2), hepatic trisegmentectomy or major hepatectomy accompanied by hepaticojejunostomy Roux-Y, and adjacent organ resection if necessary (T3). Laparoscopic or robotic surgery shows fewer postoperative complications and equivalent oncological outcomes when compared to open surgery, but much attention must be paid to avoiding injuries. In addition to surgery, novel targeted treatment along with immunotherapy and recent improvements in radiotherapy and chemotherapy (neoadjuvant-adjuvant capecitabine, cisplatin, gemcitabine) have yielded promising results even in inoperable cases calling for palliation (T4). Thus, individualized treatment must be applied.

Thoughts on some questions in the diagnose and treatment for gallbladder carcinoma

[Analysis of Treatment Modalities and Prognosis of Patients with Gallbladder Cancer in China from 2010 to 2017].

Advances and current research status of early diagnosis for gallbladder cancer

Research progress on prognostic factors of gallbladder carcinoma

The history,current status and prospect in the diagnosis and treatment of primary carcinoma of the gallbladder

[Diagnosis and treatment of carcinoma of the gall bladder]

Research advances in the pathogenesis and surgical treatment of gallbladder carcinoma

New understanding and treatment principle of precancerosis of gallbladder carcinoma

[Progress in clinical diagnosis and treatment of gallbladder cancer].

Progress in comprehensive treatment of gallbladder cancer

Current Situation and Advancement of Inchoate Diagnosis in Primary Gallbladder Carcinoma

Problems and Reflections on the Diagnosis and Treatment of Gallbladder Cancer

Gallbladder cancer: a subtype of biliary tract cancer which is a current challenge in China.

New trends in diagnosis and management of gallbladder carcinoma

DIAGNOSIS AND TREATMENT OF PRIMARY GALLBLADDER CARCINOMA WITH BILE DUCT OBSTRUCTIN

Clinical analysis on 123 patients diagnosis and treatment of primary carcinoma of gallbladder

Controversies and Considerations on Surgical Treatment of Gallbladder Cancer

Comprehensive Management of Gallbladder Cancer

The Long-Term Results of Managements in 98 Cases of Gallbladder Carcinomas

Diagnosis and treatment of gallbladder carcinoma associated with gallstones

Targeted therapy of gallbladder carcinoma